Intracoronary Abciximab With Clearway Catheter (IC-CLEARLY)

This study has been terminated.
(the study was stopped because the sample size was very difficult to achieve.)
Sponsor:
Information provided by (Responsible Party):
Gennaro Sardella, University of Roma La Sapienza
ClinicalTrials.gov Identifier:
NCT00894023
First received: May 4, 2009
Last updated: January 3, 2013
Last verified: January 2013